Works in Diabetes, Obesity & Metabolism, 2022, Vol 24, Issue 7

Results: 28

Corrigendum.

Published in:: Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1407, doi. 10.1111/dom.14728
Publication type:: Article

Corrigendum.

Published in:: Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1406, doi. 10.1111/dom.14727
Publication type:: Article

Comparison of MiniMed 780G system performance in users aged younger and older than 15 years: Evidence from 12 870 real‐world users.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1370, doi. 10.1111/dom.14714

By:

Arrieta, Arcelia;
Battelino, Tadej;
Scaramuzza, Andrea E.;
Da Silva, Julien;
Castañeda, Javier;
Cordero, Toni L.;
Shin, John;
Cohen, Ohad

Publication type:

Article

Efficacy and safety of cotadutide, a dual glucagon‐like peptide‐1 and glucagon receptor agonist, in a randomized phase 2a study of patients with type 2 diabetes and chronic kidney disease.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1360, doi. 10.1111/dom.14712

By:

Parker, Victoria E. R.;
Hoang, Thuong;
Schlichthaar, Heike;
Gibb, Fraser W.;
Wenzel, Barbara;
Posch, Maximillian G.;
Rose, Ludger;
Chang, Yi‐Ting;
Petrone, Marcella;
Hansen, Lars;
Ambery, Philip;
Jermutus, Lutz;
Heerspink, Hiddo J. L.;
McCrimmon, Rory J.

Publication type:

Article

Types of diet, obesity, and incident type 2 diabetes: Findings from the UK Biobank prospective cohort study.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1351, doi. 10.1111/dom.14711

By:

Boonpor, Jirapitcha;
Petermann‐Rocha, Fanny;
Parra‐Soto, Solange;
Pell, Jill P.;
Gray, Stuart R.;
Celis‐Morales, Carlos;
Ho, Frederick K.

Publication type:

Article

Efficacy and safety of oral semaglutide by subgroups of patient characteristics in the PIONEER phase 3 programme.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1338, doi. 10.1111/dom.14710

By:

Aroda, Vanita R.;
Bauer, Robert;
Christiansen, Erik;
Haluzík, Martin;
Kallenbach, Klaus;
Montanya, Eduard;
Rosenstock, Julio;
Meier, Juris J.

Publication type:

Article

Cost‐effectiveness of sodium‐glucose cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors among patients with type 2 diabetes with and without established cardiovascular diseases: A model‐based simulation analysis using 10‐year real‐world data and targeted literature review

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1328, doi. 10.1111/dom.14708

By:

Peng, Zi‐Yang;
Yang, Chun‐Ting;
Ou, Huang‐Tz;
Kuo, Shihchen

Publication type:

Article

In‐home use of a hybrid closed loop achieves time‐in‐range targets in preschoolers and school children: Results from a randomized, controlled, crossover trial.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1319, doi. 10.1111/dom.14706

By:

von dem Berge, Thekla;
Remus, Kerstin;
Biester, Sarah;
Reschke, Felix;
Klusmeier, Britta;
Adolph, Kerstin;
Holtdirk, Anette;
Thomas, Andreas;
Kordonouri, Olga;
Danne, Thomas;
Biester, Torben

Publication type:

Article

Early and ongoing stable glycaemic control is associated with a reduction in major adverse cardiovascular events in people with type 2 diabetes: A primary care cohort study.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1310, doi. 10.1111/dom.14705

By:

Whyte, Martin B.;
Joy, Mark;
Hinton, William;
McGovern, Andrew;
Hoang, Uy;
van Vlymen, Jeremy;
Ferreira, Filipa;
Mount, Julie;
Munro, Neil;
de Lusignan, Simon

Publication type:

Article

Association between antidiabetic drug use and the risk of COVID‐19 hospitalization in the INSIGHT Clinical Research Network in New York City.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1402, doi. 10.1111/dom.14704

By:

Min, JeaYoung;
Simmons, Will;
Banerjee, Samprit;
Wang, Fei;
Williams, Nicholas;
Zhang, Yongkang;
Reese, April B.;
Mushlin, Alvin I.;
Flory, James H.

Publication type:

Article

Healthcare costs and hospitalizations in US patients with type 2 diabetes and cardiovascular disease: A retrospective database study (OFFSET).

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1300, doi. 10.1111/dom.14703

By:

Evans, Marc;
Chandramouli, Abhishek Shankar;
Faurby, Mads;
Matthiessen, Kasper Sommer;
Mogensen, Phillip Bredahl;
Verma, Subodh

Publication type:

Article

Injectable semaglutide and reductions in HbA1c and weight in the real world in people switched from alternative glucagon‐like peptide‐1 receptor agonists.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1398, doi. 10.1111/dom.14701

By:

Crabtree, Thomas S. J.;
Adamson, Karen;
Reid, Hazel;
Barnes, Dennis;
Sivappriyan, Siva;
Bickerton, Alex;
Gallen, Ian W.;
Field, Benjamin C. T.;
Idris, Iskandar;
Ryder, Robert E. J.

Publication type:

Article

Cardiovascular efficacy of liraglutide and semaglutide in individuals with diabetes and peripheral artery disease.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1288, doi. 10.1111/dom.14700

By:

Verma, Subodh;
Al‐Omran, Mohammed;
Leiter, Lawrence A.;
Mazer, C. David;
Rasmussen, Søren;
Saevereid, Hans A.;
Sejersten Ripa, Maria;
Bonaca, Marc P.

Publication type:

Article

Efficacy, safety, tolerability, and noninferiority phase 3 study of glucagon as a ready‐to‐use room temperature liquid stable formulation versus a lyophilised formulation for the biochemical recovery and symptomatic relief of insulin‐induced severe hypoglycaemia in adults with type 1 diabetes

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1394, doi. 10.1111/dom.14699

By:

Pieber, Thomas R.;
Aronson, Ronnie;
Christiansen, Mark P.;
Bode, Bruce;
Junaidi, Khaled;
Conoscenti, Valentina

Publication type:

Article

Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countries.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1277, doi. 10.1111/dom.14698

By:

Norhammar, Anna;
Bodegard, Johan;
Eriksson, Jan W.;
Haller, Hermann;
Linssen, Gerard C. M.;
Banerjee, Amitava;
Karasik, Avraham;
Mamouris, Pavlos;
Tangri, Navdeep;
Taveira‐Gomes, Tiago;
Maggioni, Aldo P.;
Botana, Manuel;
Thuresson, Marcus;
Okami, Suguru;
Yajima, Toshitaka;
Kadowaki, Takashi;
Birkeland, Kåre I.

Publication type:

Article

Modifying chronic kidney disease progression with the mineralocorticoid receptor antagonist finerenone in patients with type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1197, doi. 10.1111/dom.14696

By:

DeFronzo, Ralph A.;
Bakris, George L.

Publication type:

Article

A low n‐6 to n‐3 polyunsaturated fatty acid ratio diet improves hyperinsulinaemia by restoring insulin clearance in obese youth.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1267, doi. 10.1111/dom.14695

By:

Tricò, Domenico;
Galderisi, Alfonso;
Van Name, Michelle A.;
Caprio, Sonia;
Samuels, Stephanie;
Li, Zhongyao;
Galuppo, Brittany T.;
Savoye, Mary;
Mari, Andrea;
Feldstein, Ariel E.;
Santoro, Nicola

Publication type:

Article

Empagliflozin and incidence of events consistent with acute kidney injury: Pooled safety analysis in more than 15 000 individuals.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1390, doi. 10.1111/dom.14694

By:

Agarwal, Rajiv;
Hauske, Sibylle Jenny;
Wheeler, David C.;
Doi, Kent;
Elsaesser, Amelie;
Ritter, Ivana;
Steubl, Dominik;
Wanner, Christoph

Publication type:

Article

The alpha‐7 nicotinic acetylcholine receptor agonist GTS‐21 engages the glucagon‐like peptide‐1 incretin hormone axis to lower levels of blood glucose in db/db mice.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1255, doi. 10.1111/dom.14693

By:

Meng, Qinghe;
Chepurny, Oleg G.;
Leech, Colin A.;
Pruekprasert, Napat;
Molnar, Megan E.;
Collier, James Jason;
Cooney, Robert N.;
Holz, George G.

Publication type:

Article

The benefit of dexamethasone in patients with COVID‐19 infection is preserved in patients with diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1385, doi. 10.1111/dom.14692

By:

Eng, Pei Chia;
Distaso, Walter;
Durreshahwar, Hashmi;
Shaikhali, Yusuf;
Narendranathan, Divani;
Cassin‐Scott, Rebecca;
Misra, Shivani;
Hill, Neil E.;
Tharakan, George;
Oliver, Nick S.;
Tan, Tricia M.;
Izzi‐Engbeaya, Chioma;
Salem, Victoria

Publication type:

Article

Cardiorenal outcomes with ertugliflozin assessed according to baseline glucose‐lowering agent: An analysis from VERTIS CV.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1245, doi. 10.1111/dom.14691

By:

Dagogo‐Jack, Samuel;
Cannon, Christopher P.;
Cherney, David Z. I.;
Cosentino, Francesco;
Liu, Jie;
Pong, Annpey;
Gantz, Ira;
Frederich, Robert;
Mancuso, James P.;
Pratley, Richard E.

Publication type:

Article

Previously unrecognized risk factors for severe hypoglycaemia requiring emergency medical care in insulin‐treated type 2 diabetes: Results from a real‐world nested case‐control study.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1235, doi. 10.1111/dom.14690

By:

Settles, Julie;
Kan, Hong;
Child, Christopher J.;
Gorritz, Magdaliz;
Multani, Jasjit K.;
McGuiness, Catherine B.;
Wade, Rolin L.;
Frier, Brian M.

Publication type:

Article

Integrated metagenomics and metabolomics analysis illustrates the systemic impact of the gut microbiota on host metabolism after bariatric surgery.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1224, doi. 10.1111/dom.14689

By:

Han, Yeyoung;
Kim, Gihyeon;
Ahn, Eunyong;
Jung, Sunhee;
Jung, Youngae;
Kim, Yunjae;
Ha, Eunyoung;
Heo, Yoonseok;
Ryu, Do Hyun;
Park, Hansoo;
Hwang, Geum‐Sook

Publication type:

Article

Changes over time in the cardiovascular risk profile of type 2 diabetes from 2007 to 2020: A community‐based study.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1216, doi. 10.1111/dom.14686

By:

Williams, Brent A.;
Brady, Jonathan P.;
Voyce, Stephen;
Kumar, Neela;
Paprocki, Yurek;
Rajpura, Jigar

Publication type:

Article

Sodium‐glucose co‐transporter‐2 inhibitors in patients with type 2 diabetes: Barriers and solutions for improving uptake in routine clinical practice.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1187, doi. 10.1111/dom.14684

By:

Khunti, Kamlesh;
Jabbour, Serge;
Cos, Xavier;
Mudaliar, Sunder;
Mende, Christian;
Bonaca, Marc;
Fioretto, Paola

Publication type:

Article

Glucagon‐like peptide‐1 receptor agonist prescribing patterns in adolescents with type 2 diabetes.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1380, doi. 10.1111/dom.14681

By:

Bensignor, Megan O.;
Wolf, Jack M.;
Rudser, Kyle D.;
Kelly, Aaron S.;
Arslanian, Silva

Publication type:

Article

Alliance of Randomized Trials of Medicine vs Metabolic Surgery in Type 2 Diabetes (ARMMS‐T2D): Study rationale, design, and methods.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1206, doi. 10.1111/dom.14680

By:

Simonson, Donald C.;
Hu, Bo;
Arterburn, David E.;
Schauer, Philip R.;
Kashyap, Sangeeta R.;
Courcoulas, Anita P.;
Cummings, David E.;
Patti, Mary‐Elizabeth;
Gourash, William F.;
Vernon, Ashley H.;
Jakicic, John M.;
Kirwan, John P.

Publication type:

Article

Diabetes, Obesity and Metabolism.

Published in:: Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1185, doi. 10.1111/dom.14431
Publication type:: Article